Physician
Oscar Garza, M.D.,Pa
Oscar Garza, M.D.,Pa was paid $785K by Medicaid between Jan 2018 and Oct 2024, across 50 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 50% of everything it billed.
33Billing provider infoOSCAR GARZA, M.D.,PA
PEARSALL, TX 78061
PEARSALL, TX 78061
33aNPI1447467030assigned 05/16/2007
33bProvider typeFamily Medicine Physician
28Total paid$785K
24GClaims35,749
24DCodes billed50
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Family Medicine Physician providers in Texas
Rank by total paid#122 of 1,204
Median peer was paid$31K
This provider vs. median25×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,855 | $6K | |
| 2019 | 2,872 | $12K | |
| 2020 | 4,029 | $63K | |
| 2021 | 9,858 | $242K | |
| 2022 | 10,860 | $288K | |
| 2023 | 4,739 | $128K | |
| 2024incomplete | 1,536 | $46K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 50% | 12,550 | 10,691 | $392K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 28% | 7,918 | 6,768 | $219K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.3% | 603 | 599 | $42K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.6% | 425 | 423 | $28K |
| 99050 | 3.1% | 1,792 | 1,686 | $24K | |
| 99490 | Ccm add 20min | 1.6% | 1,656 | 1,656 | $12K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.5% | 144 | 143 | $12K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.4% | 155 | 154 | $11K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.2% | 2,168 | 1,510 | $9K |
| 99308 | Subsequent nursing facility care, per day, straightforward | 1.1% | 1,216 | 1,044 | $9K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 206 | 190 | $5K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 336 | 317 | $4K |
38 more codes
| 92552 | <1% | 421 | $3K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 62 | $3K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 57 | $3K |
| 81003 | <1% | 1,747 | $3K | |
| 0011A | <1% | 120 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 79 | $973.00 |
| 0012A | <1% | 81 | $730.63 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 95 | $706.18 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 15 | $633.22 |
| 87400 | <1% | 54 | $607.51 | |
| 0031A | <1% | 54 | $340.68 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 30 | $303.26 |
| 99497 | <1% | 96 | $203.10 | |
| 0013A | <1% | 17 | $160.00 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 385 | $130.66 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 12 | $97.68 |
| 90662 | <1% | 74 | $52.76 | |
| 90715 | <1% | 25 | $31.50 | |
| J1020 | Injection, methylprednisolone acetate, 20 mg | <1% | 25 | $10.83 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 349 | $4.20 |
| 91301 | <1% | 312 | $0.08 | |
| 91303 | <1% | 54 | $0.02 | |
| 90670 | 0% | 476 | $0.00 | |
| 99173 | 0% | 729 | $0.00 | |
| 90734 | 0% | 47 | $0.00 | |
| 90648 | 0% | 255 | $0.00 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 0% | 168 | $0.00 |
| 90633 | 0% | 51 | $0.00 | |
| 3725F | 0% | 72 | $0.00 | |
| 90710 | 0% | 28 | $0.00 | |
| 90680 | 0% | 163 | $0.00 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 40 | $0.00 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 61 | $0.00 |
| 90686 | 0% | 106 | $0.00 | |
| 90723 | 0% | 67 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 108 | $0.00 |
| 1170F | 0% | 20 | $0.00 | |
| 90696 | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGARZA, OSCAR (OWNER)